Delivery Order SPE2DB20D9371-SPE2DB25FT1Z9
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,712.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/ml autoinjectors, with a period of performance through October 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.66 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml autoinjector on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, was issued without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The award...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,848.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injectors. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract worth $17,122.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the pharmaceutical product Xolair 150 mg/ml autoinjector, with a period of performance through September 5, 2024. This delivery order contract is part of a larger $499,999,999 indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,273.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector vials. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a specific pharmaceutical procurement supporting military healthcare operations. The award carries no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,273.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/mL auto-injector units. The delivery order, awarded on August 15, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on September 3, 2025, with completion targeted for September 24, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 15, 2025. This delivery order was issued without a set-aside designation and represents a single-line procurement under DLA's existing...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is for Xolair 300 mg/2 ml auto-injectors and is part of a larger $499,999,999 indefinite delivery contract (IDC) under the SPE2DB program that DMS Pharmaceutical Group holds with DLA. This IDC enables DLA to issue delivery orders for a comprehensive range of pharmaceutical products,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $8,561.15 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order, which is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, is for the delivery of 4,566,831,826 units of Xolair 300 mg/2 ml autoinjectors. This contract is not associated with any set-aside designation. As a key supplier in...
- SPE2DB20D9371Indefinite Delivery Contract
- SPE2DB20D9371-SPE2DB25FT1Z9Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,712.22 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml auto-injectors. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will fulfill this delivery order with a completion date of September 29, 2025. This award carries no set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace based on its qualifications and pricing competitiveness. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and extending through November 2026. The SPE2DB program vehicle enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support the medical supply requirements of Department of Defense healthcare facilities worldwide. As a established supplier in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group continues to provide critical pharmaceutical distribution services to military health facilities, with this order representing a routine fulfillment under the larger master contract agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/8/25 |